BBNX
Beta Bionics, Inc.
NASDAQ · USHealthcareMedical - Equipment & Services
$17.82+3.07%
Price as of Jul 20, 2026
BBNX profitability
Beta Bionics, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 57.2%
- EBITDA margin
- -57.6%
- EBIT margin
- -70.1%
- Net margin
- -60.3%
- Free cash flow margin
- -55.4%
Returns
- Return on equity
- -24.5%
- Return on assets
- -21.8%
- Return on invested capital
- -27.8%
- Asset turnover
- 0.35x
Cash efficiency
- Cash from operations
- -$54.8M
- Cash per share
- $4.48
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.